Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

UNCY

Unicycive Therapeutics (UNCY)

Unicycive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UNCY
DateTimeSourceHeadlineSymbolCompany
06/25/20246:30AMGlobeNewswire Inc.Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical TrialNASDAQ:UNCYUnicycive Therapeutics Inc
05/28/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
05/23/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
05/15/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
05/13/20243:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
05/13/20243:16PMGlobeNewswire Inc.Unicycive Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
05/13/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
05/08/20243:05PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:UNCYUnicycive Therapeutics Inc
04/10/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
03/28/20243:15PMGlobeNewswire Inc.Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
03/25/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
03/14/20246:03AMGlobeNewswire Inc.Unicycive Announces $50 Million Private PlacementNASDAQ:UNCYUnicycive Therapeutics Inc
03/13/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
03/07/20243:12PMGlobeNewswire Inc.Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
03/04/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant PatientsNASDAQ:UNCYUnicycive Therapeutics Inc
02/21/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
02/14/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
01/29/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
01/23/20246:03AMGlobeNewswire Inc.Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming MilestonesNASDAQ:UNCYUnicycive Therapeutics Inc
01/22/20243:27PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:UNCYUnicycive Therapeutics Inc
12/18/20236:03AMGlobeNewswire Inc.Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on DialysisNASDAQ:UNCYUnicycive Therapeutics Inc
12/08/20233:36PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:UNCYUnicycive Therapeutics Inc
11/29/20236:03AMGlobeNewswire Inc.Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023NASDAQ:UNCYUnicycive Therapeutics Inc
11/14/20233:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
11/14/20233:15PMGlobeNewswire Inc.Unicycive Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
10/23/202310:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
10/23/20236:03AMGlobeNewswire Inc.Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
09/25/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
09/07/20233:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
09/07/20233:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:UNCY